The DreaMed Advisor Pro will help healthcare providers make recommendations for changes in insulin pump therapy, and it will be integrated into Glooko software. By Craig Idlebrook/GluCraig The FDA has approved new artificial-intelligence-based software that will help healthcare professionals make insulin dosing recommendations for people with type 1 diabetes. On June 18, 2018, Israel-based […]
The move corrects a strange regulatory gap in Medicare coverage.
Medicare Will Allow Dexcom G5 CGM to Be Used with Smart, Mobile Devices